Contrast-enhanced MR imaging of postoperative scars and VX2 carcinoma in rabbits: Comparison of macromolecular contrast agent and gadopentetate dimeglumine

Radiology

Volumn 229, Issue 1, 2003, Pages 132-139

  Lee, Joon Woo ^a   Moon, Woo Kyung ^a   Weinmann, Hanns Joachim ^b   Kim, Soo Jeoung ^a   Kim, Jong Hyo ^a   Park, Seong Ho ^a   Kim, Tae Jung ^a   Yoon, Chang Jin ^a   Kim, Young Hoon ^a   Cho, Eun Yoon ^c   Ha, Sung Whan ^b   Kang, Wee Saing ^b   Chang, Kee Hyun ^a  

^a Seoul National University Hospital   (South Korea)

^b Dept of Contrast Media Research ^*

^c Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Animals; Contrast media, comparative studies; Experimental study; Gadolinium; Magnetic resonance (MR), contrast enhancement; Magnetic resonance (MR), contrast media; Neoplasms, MR

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM PENTETATE; GADOLINIUM PENTETATE MEGLUMINE; SHL 643A; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTRAST ENHANCEMENT; LIVER CARCINOMA; MACROMOLECULE; MICROVASCULATURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RABBIT; SCAR;

ANIMALS; CICATRIX; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; GADOLINIUM; GADOLINIUM DTPA; LIVER NEOPLASMS, EXPERIMENTAL; MAGNETIC RESONANCE IMAGING; MOLECULAR WEIGHT; NEOPLASM TRANSPLANTATION; RABBITS; THIGH;

EID: 0141853105     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2291020218     Document Type: Article

References (33)

1. Glazer HS, Lee JK, Levitt RG, et al. Radiation fibrosis: differentiation from recurrent tumor by MR imaging. Radiology 1985; 156:721-726.
2. Ebner F, Kressel HY, Mintz MC, et al. Tumor recurrence versus fibrosis in the female pelvis: differentiation with MR imaging at 1.5 T. Radiology 1988; 166:333-340.
3. Krestin GP, Steinbrich W, Friedmann G. Recurrent rectal cancer: diagnosis with MR imaging versus CT. Radiology 1988; 168:307-311.
4. Markus J, Morrissey B, deGara C, Tarulli G. MRI of recurrent rectosigmoid carcinoma. Abdom Imaging 1997; 22:338-342.
5. Muller-Schimpfle M, Brix G, Layer G, et al. Recurrent rectal cancer: diagnosis with dynamic MR imaging. Radiology 1993; 189:881-889.
6. de Lange EE, Fechner RE, Wanebo HJ. Suspected recurrent rectosigmoid carcinoma after abdominoperineal resection: MR imaging and histopathologic findings. Radiology 1989; 170:323-328.
7. Ito K, Kato T, Tadokoro M, et al. Recurrent rectal cancer and scar: differentiation with PET and MR imaging. Radiology 1992; 182: 549-552.
8. Rafto SE, Amendola MA, Gefter WB. MR imaging of recurrent colorectal carcinoma versus fibrosis. J Comput Assist Tomogr 1988; 12:521-523.
9. Kinkel K, Ariche M, Tardivon AA, et al. Differentiation between recurrent tumor and benign conditions after treatment of gynecologic pelvic carcinoma: value of dynamic contrast-enhanced subtraction MR imaging. Radiology 1997; 204:55-63.
10. Dao TH, Rahmouni A, Campana F, Laurent M, Asselain B, Fourquet A. Tumor recurrence versus fibrosis in the irradiated breast: differentiation with dynamic gadolinium-enhanced MR imaging. Radiology 1993; 187:751-755.
11. Ross JS, Delamarter R, Hueftle MG, et al. Gadolinium-DTPA-enhanced MR imaging of the postoperative lumbar spine: time course and mechanism of enhancement. AJR Am J Roentgenol 1989; 152:825-834.
12. Bundschuh CV, Stein L, Slusser JH, Schinco FP, Ladaga LE, Dillon JD. Distinguishing between scar and recurrent herniated disk in postoperative patients: value of contrast-enhanced CT and MR imaging. AJNR Am J Neuroradiol 1990; 11:949-958.
13. Weinmann HJ, Brasch RC, Press WR, Wesbey GE. Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent. AJR Am J Roentgenol 1984; 142:619-624.
14. Brasch RC. Rationale and applications for macromolecular Gd-based contrast agents. Magn Reson Med 1991; 22:282-287.
15. Moon WK, Chang KH, Weinmann HJ, et al. Dynamic contrast-enhanced MR imaging of bacterial abscess and VX2 carcinoma in rabbits: comparison of gadopentetate dimeglumine and a macromolecular contrast agent. AJR Am J Roentgenol 2000; 174:1385-1390.
16. Misselwitz B, Schmitt-Willich H, Ebert W, Frenzel T, Weinmann HJ. Pharmacokinetics of Gadomer-17, a new dendritic magnetic resonance contrast agent. MAGMA 2001; 12:128-134.
17. Grist TM, Korosec FR, Peters DC, et al. Steady-state and dynamic MR angiography with MS-325: initial experience in humans. Radiology 1998; 207:539-544.
18. Nguyen-minh C, Haughton VM, An HS, You JW, Wook S, Ho KC. Contrast media of high and low molecular weights in the detection of recurrent herniated disks. AJNR Am J Neuroradiol 1998; 19:889-893.
19. Demsar F, Roberts TP, Schwickert HC, et al. A MRI spatial mapping technique for microvascular permeability and tissue blood volume based on macromolecular contrast agent distribution. Magn Reson Med 1997; 37:236-242.
20. Brasch R, Pham C, Shames D, et al. Assessing tumor angiogenesis using macromolecular MR imaging contrast media. J Magn Reson Imaging 1997; 7:68-74.
21. Li D, Zheng J, Weinmann HJ. Contrast-enhanced MR imaging of coronary arteries: comparison of intra- and extravascular contrast agents in swine. Radiology 2001; 218:670-678.
22. Jeong AK, Choi SI, Kim DH, et al. Evaluation by contrast-enhanced MR imaging of the lateral border zone in reperfused myocardial infarction in a cat model. Korean J Radiol 2001; 2:21-27.
23. Henderson E, Sykes J, Drost D, Weinmann HJ, Rutt BK, Lee TY. Simultaneous MRI measurement of blood flow, blood volume, and capillary permeability in mammary tumors using two different contrast agents. J Magn Reson Imaging 2000; 12:991-1003.
24. Clarke SE, Weinmann HJ, Dai E, Lucas AR, Rutt BK. Comparison of two blood pool contrast agents for 0.5-T MR angiography: experimental study in rabbits. Radiology 2000; 214:787-794.
25. Tacke J, Adam G, Classen H, Muhler A, Prescher A, Gunther RW. Dynamic MRI of a hypovascularized liver tumor model: comparison of a new blood pool contrast agent (24-gadolinium-DTPA-cascade-polymer) with gadopentetate dimeglumine. J Magn Reson Imaging 1997; 7:678-682.
26. Adam G, Muhler A, Spuntrup E, et al. Differentiation of spontaneous canine breast tumors using dynamic magnetic resonance imaging with 24-gadolinium-DTPA-cascade-polymer, a new blood-pool agent: preliminary experience. Invest Radiol 1996; 31:267-274.
27. Jain RK. Transport of molecules across tumor vasculature. Cancer Metastasis Rev 1987; 6:559-593.
28. Su MY, Wang Z, Nalcioglu O. Investigation of longitudinal vascular changes in control and chemotherapy-treated tumors to serve as therapeutic efficacy predictors. J Magn Reson Imaging 1999; 9:128-137.
29. Erlemann R, Reiser MF, Peters PE, et al. Musculoskeletal neoplasms: static and dynamic Gd-DTPA-enhanced MR imaging. Radiology 1989; 171:767-773.
30. Fletcher BD, Hanna SL, Fairclough DL, Gronemeyer SA. Pediatric musculoskeletal tumors: use of dynamic, contrast-enhanced MR imaging to monitor response to chemotherapy. Radiology 1992; 184: 243-248.
31. Kuhl CK, Mielcareck P, Klaschik S, et al. Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? Radiology 1999; 211:101-110.
32. Orel SG. Differentiating benign from malignant enhancing lesions identified at MR imaging of the breast: are time-signal intensity curves an accurate predictor? (editorial). Radiology 1999; 211:5-7.
33. Verhoye M, van der Sanden BP, Rijken PF, et al. Assessment of the neovascular permeability in glioma xenografts by dynamic T1 MRI with Gadomer-17. Magn Reson Med 2002; 47:305-313.